Large-Scale Drug Screening in Patient-Derived IDH(mut) Glioma Stem Cells Identifies Several Efficient Drugs among FDA-Approved Antineoplastic Agents

The discovery of the isocitrate dehydrogenase (IDH) mutation in glioma led to a paradigm shift on how we see glioma biology. Difficulties in cultivating IDH mutant glioma stem cells (IDH(mut) GSCs) resulted in a paucity of preclinical models in IDH(mut) glioma, limiting the discovery of new effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Dao Trong, Philip, Jungwirth, Gerhard, Yu, Tao, Pusch, Stefan, Unterberg, Andreas, Herold-Mende, Christel, Warta, Rolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348988/
https://www.ncbi.nlm.nih.gov/pubmed/32503220
http://dx.doi.org/10.3390/cells9061389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348988/
https://www.ncbi.nlm.nih.gov/pubmed/32503220
http://dx.doi.org/10.3390/cells9061389

Ejemplares similares